Nationwide Fund Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
EIP
Nationwide Fund Advisors's AZN Position: Q4 2017 in Review
Nationwide Fund Advisors sold out of AstraZeneca (AZN) in Q4 2017, closing a stake of 26,650 shares — an estimated $1.81M sold.
Nationwide Fund Advisors first reported a position in AZN in Q3 2013 and held it in 16 quarters. The position peaked at $13.6M in Q1 2015. 503 funds tracked by Wall St. Rank hold AZN as of Q4 2017.
- Nationwide Fund Advisors reported no remaining AstraZeneca position as of Q4 2017 after selling out during the quarter.
- Nationwide Fund Advisors sold 26,650 AstraZeneca shares in Q4 2017, an estimated $1.81M.
- Nationwide Fund Advisors first reported a position in AstraZeneca in Q3 2013 and held it in 16 quarters.
- Nationwide Fund Advisors's AstraZeneca position peaked at $13.6M in Q1 2015.
- 503 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2017.
Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.